Keywords: |
adult; cancer survival; aged; middle aged; gene mutation; genetics; mutation; mortality; cancer risk; note; nuclear magnetic resonance imaging; salpingooophorectomy; neoplasm; neoplasms; chemoprophylaxis; quality of life; ovary cancer; breast cancer; mastectomy; ovariectomy; editorial; brca1 protein; brca2 protein; heterozygote; genital neoplasms, female; tumor suppressor gene; genes, brca1; genes, brca2; tamoxifen; risk reduction; gynecologic cancer; female genital tract tumor; risk reduction behavior; raloxifene; uterine tube; fallopian tubes; decision support techniques; decision support system
|